J. Michael Dixon

Breakthrough Breast Cancer Research Unit, University of Edinburgh

Research Area

Biography

J. Michael Dixon has not added Biography.
If you are J. Michael Dixon and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 11	2011

Other Publications

Article	Year
The value of adjuvant treatment in young women with breast cancer. Drugs\| PubMed ID: 11790154	2002
One stop clinics should not be abandoned. BMJ (Clinical research ed.)\| PubMed ID: 11876172	2002
Endocrine and clinical endpoints of exemestane as neoadjuvant therapy. Cancer control : journal of the Moffitt Cancer Center\| PubMed ID: 11965226	2002
Exemestane: a potent irreversible aromatase inactivator and a promising advance in breast cancer treatment. Expert review of anticancer therapy\| PubMed ID: 12113050	2002
Postcode prescribing is alive and well in Scotland. BMJ (Clinical research ed.)\| PubMed ID: 12114247	2002
Breast cancer: non-metastatic. Clinical evidence\| PubMed ID: 12230775	2002
Message about hormone replacement therapy is unclear. BMJ (Clinical research ed.)\| PubMed ID: 12411373	2002
Breast cancer: non-metastatic. Clinical evidence\| PubMed ID: 12603971	2002
Breast cancer (non-metastatic). Clinical evidence\| PubMed ID: 12967459	2003
Exemestane and aromatase inhibitors in the management of advanced breast cancer. Expert opinion on pharmacotherapy\| PubMed ID: 14996627	2004
Role of endocrine therapy in the neoadjuvant surgical setting. Annals of surgical oncology\| PubMed ID: 15015705	2004
The scientific value of preoperative studies and how they can be used. Breast cancer research and treatment\| PubMed ID: 15597217	2004
Breast cancer (non-metastatic). Clinical evidence\| PubMed ID: 15652112	2004
Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 15701892	2005
Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 15767642	2005
Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPA... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 15998903	2005
Surgical issues surrounding use of aromatase inhibitors. The Journal of steroid biochemistry and molecular biology\| PubMed ID: 16023854	2005
Breast cancer (non-metastatic). Clinical evidence\| PubMed ID: 16135326	2005
Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours. BMC cancer\| PubMed ID: 16156888	2005
Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with e... Breast cancer research and treatment\| PubMed ID: 16163445	2006
Proliferation and apoptosis as markers of benefit in neoadjuvant endocrine therapy of breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16467120	2006
Neoadjuvant endocrine therapy models. Methods in molecular medicine\| PubMed ID: 16491621	2006
Screening for breast cancer. BMJ (Clinical research ed.)\| PubMed ID: 16513688	2006
The prevention, detection, and management of breast cancer. The Medical journal of Australia\| PubMed ID: 16515434	2006
Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. Journal of the National Cancer Institute\| PubMed ID: 16670385	2006
Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 16754938	2006
Extended adjuvant therapy with letrozole: reducing the risk of recurrence. Expert review of anticancer therapy\| PubMed ID: 16761928	2006
Proceedings of the Consensus Conference on Breast Conservation, April 28 to May 1, 2005, Milan, Italy. Cancer\| PubMed ID: 16770785	2006
Consensus conference on breast conservation. Journal of the American College of Surgeons\| PubMed ID: 16864033	2006
Estrogen receptor alpha positive breast tumors and breast cancer cell lines share similarities in their transcriptome data structures. International journal of oncology\| PubMed ID: 17089000	2006
Neoadjuvant use of hormonal therapy in elderly patients with early or locally advanced hormone receptor-positive breast cancer. The oncologist\| PubMed ID: 17110627	2006
Aromatase inhibitors in early breast cancer therapy: a variety of treatment strategies. Expert opinion on pharmacotherapy\| PubMed ID: 17150002	2006
Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer. Journal of the National Cancer Institute\| PubMed ID: 17228000	2007
Neoadjuvant use of endocrine therapy in breast cancer. The breast journal\| PubMed ID: 17461898	2007
Molecular response to aromatase inhibitor treatment in primary breast cancer. Breast cancer research : BCR\| PubMed ID: 17555561	2007
DCIS and aromatase inhibitors. The Journal of steroid biochemistry and molecular biology\| PubMed ID: 17604618	2007
Aromatase inhibitors--gene discovery. The Journal of steroid biochemistry and molecular biology\| PubMed ID: 17616392	2007
Breast abscess. British journal of hospital medicine (London, England : 2005)\| PubMed ID: 17639835	2007
Predicting response and resistance to endocrine therapy: profiling patients on aromatase inhibitors. Cancer\| PubMed ID: 18072233	2008
Increase in response rate by prolonged treatment with neoadjuvant letrozole. Breast cancer research and treatment\| PubMed ID: 18264759	2009
Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer. Expert review of anticancer therapy\| PubMed ID: 18366292	2008
Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 18375896	2008
Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 18474876	2008
Reducing early recurrence with adjuvant aromatase inhibitors: what is the evidence? Breast (Edinburgh, Scotland)\| PubMed ID: 18490163	2008
Predictors of mastectomy in a certified breast center - the surgeon is an independent risk factor. The breast journal\| PubMed ID: 18537918	2008
Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms. Cancer research\| PubMed ID: 18632656	2008
Adjuvant endocrine therapy for perimenopausal women with early breast cancer. Breast (Edinburgh, Scotland)\| PubMed ID: 19036588	2009
Introduction to sessions on 'What can surgeons do for us (and we for them): radiology, pathology, molecular biology and local therapy'. Breast cancer research : BCR\| PubMed ID: 19128433	2008
Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors: the case for. Breast cancer research : BCR\| PubMed ID: 19128445	2008
Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 19224856	2009
Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 19380449	2009
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 19666588	2009
Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact o... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 19805685	2009
A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer. Breast cancer research and treatment\| PubMed ID: 19941160	2010
Breast screening has increased the number of mastectomies. Breast cancer research : BCR\| PubMed ID: 20030870	2009
Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors. Cancer research\| PubMed ID: 20048079	2010
So you want to be ... a breast surgeon. British journal of hospital medicine (London, England : 2005)\| PubMed ID: 20081651	2010
Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer. Breast cancer research and treatment\| PubMed ID: 20107891	2010
Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled tri... Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 20179229	2010
Correcting for intra-experiment variation in Illumina BeadChip data is necessary to generate robust gene-expression profiles. BMC genomics\| PubMed ID: 20181233	2010
Combining and sequencing adjuvant chemotherapy and tamoxifen in postmenopausal women with node-positive breast cancer. Women's health (London, England)\| PubMed ID: 20426600	2010
Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer. Breast cancer research and treatment\| PubMed ID: 20480226	2010
A further survey of surgical management of the axilla in UK breast cancer patients. Annals of the Royal College of Surgeons of England\| PubMed ID: 20522293	2010
Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer. Breast cancer research : BCR\| PubMed ID: 20569502	2010
对早期侵袭性乳腺癌患者保乳治疗局部复发的外科边&#x8DD... European journal of cancer (Oxford, England : 1990)\| PubMed ID: 20817513	2010
Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability. Breast cancer research and treatment\| PubMed ID: 20821047	2011
DCIS of the breast: Are we over-diagnosing it? Are we over-treating it? Maturitas\| PubMed ID: 21273014	2011
Treatment of breast infection. BMJ (Clinical research ed.)\| PubMed ID: 21317199	2011
Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer. Molecular cancer\| PubMed ID: 21320304	2011
Implant-Based Augmentation Mammaplasty Following Breast Conservation Surgery. Annals of plastic surgery\| PubMed ID: 21346535	2011
Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 21368160	2011
Invasive lobular carcinoma: response to neoadjuvant letrozole therapy. Breast cancer research and treatment\| PubMed ID: 21870129	2011
Constructing tissue microarrays from core needle biopsies of breast cancers. Histopathology\| PubMed ID: 21906129	2011
Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer. Endocrine-related cancer\| PubMed ID: 21984694	2011
Determining tamoxifen sensitivity using primary breast cancer tissue in collagen-based three-dimensional culture. Biomaterials\| PubMed ID: 22048005	2012
Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome research\| PubMed ID: 22106369	2011
Relative impact of key sources of systematic noise in Affymetrix and Illumina gene-expression microarray experiments. BMC genomics\| PubMed ID: 22133085	2011
Congenital abnormalities of the breast. Women's health (London, England)\| PubMed ID: 22171777	2012
Impact of Screening and Risk Factors for Local Recurrence and Survival After Conservative Surgery and Radiotherapy for Early Breast Cancer: Results from a Large Series with Long-Term Follow-... International journal of radiation oncology, biology, physics\| PubMed ID: 22197227	2011